Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Modified E2 Glycoprotein of Hepatitis C Virus Enhances Proinflammatory Cytokines and Protective Immune Response

Journal of Virology(2022)10.1128/jvi.00523-22Source: DataRank Database

Modified E2 Glycoprotein of Hepatitis C Virus Enhances Proinflammatory Cytokines and Protective Immune Response is a research paper published in Journal of Virology (2022). On theSindex it has a DataRank of 0. It has been cited 21 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access21 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 2.37)OA: greenTopics (69)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Tapas Patra ORCID,Keith Meyer ORCID,Mohamad‐Gabriel Alameh ORCID,Erin K. Reagan ORCID,Drew Weissman ORCID

Live enrichment

PubMed:35612312 PMC:PMC9215226 OpenAlex:https://openalex.org/W4281476186

HHS | National Institutes of Health

Grant: R01DK122401

HHS | National Institutes of Health

Grant: R01AI124429

NIAID NIH HHS

Grant: R01 AI068769

National Institutes of Health

Grant: 5R01AI124429-03

Nucleoside modified mRNA based HIV vaccine

National Institutes of Health

Grant: 5R01DK122401-03

SELECTION OF VACCINE ANTIGENS FOR PROTECTION FROM HEPATITIS C VIRUS INFECTION

FWCI

2.37

Citation Percentile

0.9%

Citation Trend

2022

2023

2024

2025

2026

greenLicense: https://doi.org/10.1128/ASMCopyrightv2

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9215226

GREENhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9215226

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9215226

publisherhttps://journals.asm.org/doi/pdf/10.1128/jvi.00523-22

journalhttps://doi.org/10.1128/jvi.00523-22

Fields of Study

Hepatitis C virus researchHepatitis B Virus StudiesLiver Disease Diagnosis and TreatmentBiologyMedicine0301 basic medicine03 medical and health sciencesAnimalsAntibodies, NeutralizingCytokinesHepacivirusHepatitis CHepatitis C AntibodiesImmunityImmunoglobulin GLiposomesMiceMice, Inbred BALB CNanoparticlesRNA, MessengerTetraspanin 28Viral Envelope ProteinsmRNA Vaccines

MeSH Terms

mRNA VaccinesAnimalsHepatitis CImmunoglobulin GImmunityLiposomesMice, Inbred BALB CRNA, MessengerViral Envelope ProteinsHepacivirusCytokinesHepatitis C AntibodiesMiceNanoparticlesAntibodies, NeutralizingTetraspanin 28

Keywords

Proinflammatory cytokineBiologyImmune systemVirologyGlycoproteinImmunologyVirusHepatitis C virusInflammationMolecular biologyProinflammatory ResponseVaccine AntigenModified E2Vaccine Antigen SelectionMice, Inbred BALB CImmunityHepacivirusHepatitis C AntibodiesAntibodies, NeutralizingHepatitis CTetraspanin 28MiceViral Envelope ProteinsImmunoglobulin GLiposomesAnimalsCytokinesNanoparticlesRNA, MessengermRNA Vaccines

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Modified E2 Glycoprotein of Hepatitis C Virus Enhances Proinflammatory Cytokines and Protective Immune Response

FAIR Checklist

Authors (7)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)